MUCUS RELIEF- guaifenesin 400 mg tablet 
Cabinet Health, Inc.

----------

ValuMeds Mucus Relief Caplets Guaifenesin 400mg

Active ingredient (in each tablet)

Guaifenesin 400 mg

Purpose

Expectorant

Uses

Warnings

ask a doctor before use if you have

When using this product

  • do not exceed recommended dosage
  • do not use for more than 7 days

Stop use and ask a doctor if

  • cough lasts for more than 7 days, recurs, or is accompanied by fever, rash, or persistent headache.

These could be signs of a serious condition.

If pregnant or breast-feeding,ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions:

Other information

Inactive ingredients

colloidal silicon dioxide, magnesium stearate, microcrystalline cellulose, stearic acid, sodium starch glycolate

Questions or Comments

contact 1-908-242-6108 Mon- Fri 8:00 AM EST to 5:00 PM

Principal Display Panel

ValuMeds Mucus Relief Caplets Guaifenesin 400mg (200 Caplets) | Chest Congestion and Decongestant | Thins and Loosens Buildup | Fast Acting

NDC 82725-1012-1

Valumed Guaifenesin

MUCUS RELIEF 
guaifenesin 400 mg tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:82725-1012
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN400 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
POVIDONE (UNII: FZ989GH94E)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
Product Characteristics
ColorwhiteScoreno score
ShapeOVALSize17mm
FlavorImprint Code S400
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:82725-1012-1200 in 1 BOTTLE; Type 0: Not a Combination Product11/01/2024
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01211/01/2024
Labeler - Cabinet Health, Inc. (117102391)

Revised: 11/2024
Document Id: 26a553a4-66ba-b5ca-e063-6294a90af31c
Set id: 26a51b0e-039c-663c-e063-6394a90ad384
Version: 1
Effective Time: 20241111
 
Cabinet Health, Inc.